The table below shows Revolution Medicines, Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Revenue
-
-
-
-
$0.00
$0.00
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$343.97M
$262.51M
$224.13M
$205.75M
$151.75M
$134.93M
SG&A
RVMD annual revenue (10-K history)
Revolution Medicines, Inc. reported annual revenue of $0.00 for fiscal year 2025. Over the 8 fiscal years shown, annual revenue declined from $20.16M (FY 2018) to $0.00. Figures come from the company's audited annual reports as filed with the SEC.